Since TGFβ is a well-known inducer of EMT during both development and cancer progression [21,30], we sought to test the effects of TGFβ on PEAK1 and E-Cadherin expression in MCF10A cells alongside three cellular models of breast cancer. The gene discussed is PEAK1; the disease is breast cancer.